Cargando…
DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder
So far, genetic studies of treatment response in schizophrenia, bipolar disorder, and major depression have returned results with limited clinical utility. A gene × environment interplay has been proposed as a factor influencing not only pathophysiology but also the treatment response. Therefore, ep...
Autores principales: | Goud Alladi, Charanraj, Etain, Bruno, Bellivier, Frank, Marie-Claire, Cynthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213157/ https://www.ncbi.nlm.nih.gov/pubmed/30287754 http://dx.doi.org/10.3390/ijms19103026 |
Ejemplares similares
-
Matrixmetalloproteinase-9 gene polymorphism (rs 17576) increases the risk of depressive symptoms in bipolar disorder
por: Saravanan, Kothandan, et al.
Publicado: (2022) -
Methylomic Biomarkers of Lithium Response in Bipolar Disorder: A Proof of Transferability Study
por: Marie-Claire, Cynthia, et al.
Publicado: (2022) -
The role of childhood trauma in bipolar disorders
por: Aas, Monica, et al.
Publicado: (2016) -
Can an Integrated Science Approach to Precision Medicine Research Improve Lithium Treatment in Bipolar Disorders?
por: Scott, Jan, et al.
Publicado: (2018) -
A DNA methylation signature discriminates between excellent and non-response to lithium in patients with bipolar disorder type 1
por: Marie-Claire, C., et al.
Publicado: (2020)